Low-Dose Unfractionated Heparin with Sequential Enoxaparin in Patients with Diabetes Mellitus and Complex Coronary Artery Disease during Elective Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Low-Dose Unfractionated Heparin with Sequential Enoxaparin in Patients with Diabetes Mellitus and Complex Coronary Artery Disease during Elective Percutaneous Coronary Intervention

Published:2018-04-05 Issue:7 Volume:131 Page:764-769
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Huang Ji,Li Nan,Li Zhao,Hou Xue-Jian,Li Zhi-Zhong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference21 articles.

1. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants;Danaei;Lancet,2011

2. Current concepts on coronary revascularization in diabetic patients;Roffi;Eur Heart J,2011

3. 5-year follow-up of coronary revascularization in diabetic patients with multivessel coronary artery disease: Insights from ARTS (arterial revascularization therapy study)-II and ARTS-I trials;Onuma;JACC Cardiovasc Interv,2011

4. Enoxaparin vs.unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial;Ferguson;JAMA,2004

5. Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: Systematic review and meta-analysis;Silvain;BMJ,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of sulfates on low molecular weight heparin using mass spectrometry: structural characterization of enoxaparin;Expert Review of Proteomics;2018-05-31